CJC-1295 DAC is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life researched for sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass. For beginners, start at the lower end of the dosage range (1-2 mg per injection) and administer once or twice weekly via subcutaneous injection.
What Is CJC-1295 DAC?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin.
It is researched for its potential effects on sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass. The only GHRH analog with extended half-life allowing once-weekly dosing — but this convenience comes at the cost of sustained supraphysiological GH levels that bypass natural feedback, which is why most researchers prefer the no-DAC version.
For beginners: This guide assumes no prior peptide experience. We'll cover everything from what CJC-1295 DAC is to how to reconstitute, inject, and structure your first cycle.
How Does CJC-1295 DAC Work?
Binds GHRH receptors on pituitary somatotrophs to stimulate GH synthesis and secretion. The DAC module covalently binds to endogenous albumin, extending the half-life to 6-8 days while maintaining receptor bioavailability. This creates sustained, elevated GH levels rather than the pulsatile release seen with CJC-1295 no DAC.
Understanding the mechanism helps set realistic expectations about what CJC-1295 DAC can and cannot do.
How Do You Get Started With CJC-1295 DAC?
Step 1 — Source: Purchase CJC-1295 DAC from a vendor with third-party Certificate of Analysis (COA) testing. This confirms purity (aim for 98%+) and rules out contamination.
Step 2 — Supplies: You'll need bacteriostatic water, insulin syringes (1mL/100-unit), alcohol swabs, and a clean workspace.
Step 3 — Reconstitute: Add BAC water to the CJC-1295 DAC vial — use our peptide calculator for exact amounts. Let the water run down the side of the vial; never spray directly on the powder. Swirl gently.
Step 4 — Dose: Draw 1-2 mg per injection using the calculator's syringe unit conversion.
Step 5 — Inject: Clean the injection site with alcohol. Pinch a fold of abdominal fat and insert the needle at 45° for subcutaneous injection. Push the plunger slowly and hold for 5 seconds.
Calculate Your CJC-1295 DAC Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295 DAC.
Open Calculator →What Should Your First CJC-1295 DAC Cycle Look Like?
Dosage: Start at the lower end of 1-2 mg per injection. This lets you assess tolerance before committing to a full cycle.
Frequency: once or twice weekly via subcutaneous injection.
Duration: 12-16 weeks. Don't cut cycles short — many GHRH analog with extended half-life effects take weeks to fully manifest.
Off-cycle: Plan a 4-week break before starting another cycle.
What Side Effects Should Beginners Watch For?
Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
As a beginner, track everything — dose, time, injection site, and any effects (positive or negative). This data helps optimize future cycles.
What Are Common Beginner Mistakes?
Not using BAC water: Sterile water lacks the preservative that prevents bacterial growth. Always use bacteriostatic water.
Inconsistent dosing: Skipping doses or varying timing significantly reduces outcomes. Set a daily alarm.
Poor storage: Reconstituted CJC-1295 DAC must stay refrigerated at 2-8°C. Leaving it at room temperature degrades the compound rapidly.
Buying cheap: Low-cost peptides without COA testing may be underdosed, contaminated, or mislabeled. Quality matters more than price.
Bottom Line for CJC-1295 DAC Beginners
Start at the lower end of 1-2 mg per injection, dose once or twice weekly, cycle for 12-16 weeks, and track everything. Source from COA-tested vendors and follow proper reconstitution protocol.
Read our complete peptide beginner's guide for general peptide education beyond CJC-1295 DAC.
Complete Guide
CJC-1295 DAC : Benefits, Dosage, Side Effects & Research
Related Reading
- CJC-1295 DAC Dosage Guide
- CJC-1295 DAC Benefits
- CJC-1295 DAC Side Effects
- CJC-1295 DAC Stacking Guide
- CJC-1295 DAC Cycle Guide
- CJC-1295 DAC Research
Research-Grade Sourcing
If you're going to research CJC-1295 DAC, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is CJC-1295 DAC?
CJC-1295 DAC (CJC-1295 with Drug Affinity Complex) is a GHRH analog with extended half-life. Synthetic GHRH analog with four amino acid substitutions conjugated to a drug affinity complex that binds endogenous albumin. It is researched for sustained GH elevation, elevated IGF-1 levels, enhanced protein synthesis, improved body composition, increased muscle mass.
What is the recommended CJC-1295 DAC dosage?
Common dosages: 1-2 mg per injection administered once or twice weekly via subcutaneous injection. Cycle length: 12-16 weeks. Half-life: 6-8 days. Use our peptide calculator for exact reconstitution math.
What are the side effects of CJC-1295 DAC?
Water retention, joint aches, fluid retention, mild headache. Sustained GH elevation may cause more pronounced side effects than pulsatile release versions. One subject death in Phase II trial was attributed to unrelated coronary artery disease.
Is CJC-1295 DAC safe?
CJC-1295 DAC has shown a preliminary safety profile in research. Not FDA-approved. Development discontinued post-Phase II. WADA banned. Available as research peptide. All research should follow appropriate safety protocols.